PDHK

丙酮酸脱氢酶 (PDHK) 是葡萄糖降解中不可逆步骤的催化剂,其活性受高度特异性蛋白激酶丙酮酸脱氢酶激酶 (PDHK/PDK) 的调节。PDHK 属于线粒体蛋白激酶家族,与其他真核蛋白激酶不同。PDHK 通过对丙酮酸脱氢酶部分中的三个丝氨酸残基进行磷酸化,使多酶线粒体丙酮酸脱氢酶复合物失活,从而在控制葡萄糖稳态中发挥重要作用。

人类有四种 PDHK 亚型 (1 至 4)。PDHK 亚型在肥胖、糖尿病、心力衰竭和癌症中上调,是这些重要人类疾病的潜在治疗靶点。

Pyruvate dehydrogenase is a catalyst for an irreversible step in the degradation of glucose and its activity is regulated by a highly specific protein kinase, pyruvate dehydrogenase kinase (PDHK/PDK). PDHK belongs to a family of mitochondrial protein kinases unique from other eukaryotic protein kinases. PDHK inactivates the multienzyme mitochondrial pyruvate dehydrogenase complex by the phosphorylation of three seryl residues in the pyruvate dehydrogenase moiety, and thus plays an important role in the control of glucose homeostasis.

There are four isoforms of PDHK (1 to 4) in humans. PDHK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
GSK-7227

GSK-7227(compound 32)是一种具有调节相关基因表达活性的PPARδ部分激动剂,在骨骼肌细胞中对PPARδ靶基因CPT1a和PDK4具有部分激动作用。

1067214-81-6
Agonist
GSK-7227

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础